Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (331-340 of 346) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trialChristoph Röllig, Martin Bornhäuser, Michael Kramer, et al.
Blood|December 14, 2011
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17pKai Neben, Henk M Lokhorst, Anna Jauch, et al.
BMC Cancer|April 27, 2016
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myelomaMarc-Andrea Baertsch, Jana Schlenzka, Elias K Mai, et al.
Blood|June 23, 2018
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associationsAndrea Pellagatti, Richard N Armstrong, Violetta Steeples, et al.
Blood|June 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaSascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, et al.
Blood|November 1, 2011
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVAlice Fabarius, Armin Leitner, Andreas Hochhaus, et al.
Cancer Cell|March 7, 2017
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma TreatmentAnja Seckinger, Jose Antonio Delgado, Samuel Moser, et al.
Nature|August 3, 2018
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDH<sup>mut</sup>-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
British Journal of Haematology|February 2, 2021
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative StudySabine Kayser, Robert K Hills, Ralitsa Langova, et al.
Pageof 35

Showing results (331-340 of 346) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trialChristoph Röllig, Martin Bornhäuser, Michael Kramer, et al.
Blood|December 14, 2011
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17pKai Neben, Henk M Lokhorst, Anna Jauch, et al.
BMC Cancer|April 27, 2016
Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myelomaMarc-Andrea Baertsch, Jana Schlenzka, Elias K Mai, et al.
Blood|June 23, 2018
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associationsAndrea Pellagatti, Richard N Armstrong, Violetta Steeples, et al.
Blood|June 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaSascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, et al.
Blood|November 1, 2011
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVAlice Fabarius, Armin Leitner, Andreas Hochhaus, et al.
Cancer Cell|March 7, 2017
Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma TreatmentAnja Seckinger, Jose Antonio Delgado, Samuel Moser, et al.
Nature|August 3, 2018
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDH<sup>mut</sup>-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Nature|November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylationSimon Raffel, Mattia Falcone, Niclas Kneisel, et al.
British Journal of Haematology|February 2, 2021
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative StudySabine Kayser, Robert K Hills, Ralitsa Langova, et al.
Pageof 35